Table 1.
Best objective response | TKI-naïve viral HCC, n = 15 | TKI-naïve nonviral HCC, n = 11 | TKI-experienced viral HCC, n = 6 | TKI-experienced nonviral HCC, n = 4 |
---|---|---|---|---|
Total evaluable (%) | 15 (100) | 11 (100) | 6 (100) | 4 (100) |
Objective response (%) | 4 (26.7) | 1 (9.1) | 0 | 0 |
Complete response | 2 (13.3) | 0 | 0 | 0 |
Partial response | 2 (13.3) | 1 (9.1) | 0 | 0 |
Stable disease (%) | 7 (46.7) | 7 (63.6) | 6 (100) | 4 (100) |
Progressive disease (%) | 4 (26.7) | 3 (27.3) | 0 | 0 |